Patents Assigned to Concert Phamaceuticals, Inc.
  • Morphinan compounds
    Patent number: 9266837
    Abstract: This invention relates to novel morphinan compounds and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a ?1 receptor agonist that also has NMDA antagonist activity.
    Type: Grant
    Filed: November 18, 2014
    Date of Patent: February 23, 2016
    Assignee: Concert Phamaceuticals, Inc.
    Inventors: Philip B. Graham, I. Robert Silverman